Article Versions Notes

Hamdy J, Emadeldin N, Hamed MM, Frakolaki E, Katsamakas S, Vassilaki N, Zoidis G, Hirsch AKH, Abdel-Halim M, Abadi AH. Design and Synthesis of Novel Bis-Imidazolyl Phenyl Butadiyne Derivatives as HCV NS5A Inhibitors. Pharmaceuticals. 2022; 15(5):632. https://doi.org/10.3390/ph15050632

Hamdy, Jehad, Nouran Emadeldin, Mostafa M. Hamed, Efseveia Frakolaki, Sotirios Katsamakas, Niki Vassilaki, Grigoris Zoidis, Anna K. H. Hirsch, Mohammad Abdel-Halim, and Ashraf H. Abadi. 2022. "Design and Synthesis of Novel Bis-Imidazolyl Phenyl Butadiyne Derivatives as HCV NS5A Inhibitors" Pharmaceuticals 15, no. 5: 632. https://doi.org/10.3390/ph15050632

Hamdy, J., Emadeldin, N., Hamed, M. M., Frakolaki, E., Katsamakas, S., Vassilaki, N., Zoidis, G., Hirsch, A. K. H., Abdel-Halim, M., & Abadi, A. H. (2022). Design and Synthesis of Novel Bis-Imidazolyl Phenyl Butadiyne Derivatives as HCV NS5A Inhibitors. Pharmaceuticals, 15(5), 632. https://doi.org/10.3390/ph15050632